The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies inAfrica risks patient safety and endangers the future of malaria treatment.

Malaria country governments, donors, UN agencies, and advocates should focus on policy reforms needed to achieve sustained improvement in malaria treatment outcomes in Africa.

An on-the-ground report on how malaria control is going in Uganda.

Prospects for malaria control are now brighter than they have been in decades.

USAID's approach to fighting malaria by building in-country capacity to control malaria will be the true test of its reforms moving forward.

A significant portion of antimalarial drugs in Africa have been illegally diverted from the public sector, where they were intended to be dispensed free of charge in public health facilities, to the private sector.

The Global Fund is to be commended for its transparency, but it has failed to act on the information it has gleaned, and continues to allow its funds to be used by governmental distribution systems known to be corrupt.